BUB1B and neoplasm: Of note, we found BUB1B/BUBR1 as the most upregulated protein in CRT-recurrent tumor as compared with the primary treatment-naïve tumor (Fig. 1b) and immunoblotting from the corresponding samples confirmed the upregulation of BUB1B/BUBR1 in CRT-recurrent tumor.